The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 Genitourinary Cancers Symposium ...
Hosted on MSN2mon
Cystoscopy: Everything You Need to KnowYour cystoscopy may involve a white or blue light to visualize the bladder and urethra. Blue light cystoscopy may be better for detecting bladder cancer. A solution of saline or sterile water will ...
Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 128.6 million in the fourth quarter of 2024 (Q4 2023: NOK 114.2 million) and EBITDA of NOK 8.5 million (NOK 29.9 million).
PhotoCure ASA (PHCUF) reports robust Q4 performance with significant revenue growth in the US and Europe, while navigating operational challenges and strategic opportunities.
The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results